Related Experiment Video
Updated: Apr 14, 2026
11:24
Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
Published on: October 18, 2011
14.8K
GnRH replacement rescues cognition in Down syndrome.
Maria Manfredi-Lozano1,2, Valerie Leysen1,2, Michela Adamo3,4
1Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, UMR-S 1172, Labex DistAlz, Lille, France.
Science (New York, N.Y.)
|September 1, 2022
Summary
Restoring gonadotropin-releasing hormone (GnRH) levels improved cognitive and olfactory deficits in Down syndrome (DS) models and patients. Pulsatile GnRH therapy shows promise for treating neurological symptoms in DS.
Area of Science:
- Neuroscience
- Genetics
- Endocrinology
Background:
- Down syndrome (DS) presents significant cognitive and olfactory deficits with no current effective treatments.
- These neurological symptoms in DS models correlate with decreased gonadotropin-releasing hormone (GnRH) expression and altered microRNA-gene networks.
- Dysregulation of GnRH neuron maturation and hippocampal synaptic transmission are implicated in DS-related neurological impairments.
Purpose of the Study:
- To investigate the role of gonadotropin-releasing hormone (GnRH) in cognitive and olfactory deficits in Down syndrome (DS).
- To evaluate the therapeutic potential of restoring GnRH levels for neurological symptoms in DS.
Main Methods:
- Utilized Ts65Dn mice as a model for Down syndrome (DS).
- Employed epigenetic, cellular, chemogenetic, and pharmacological interventions to modulate GnRH levels.
- Administered pulsatile GnRH therapy to DS patients.
Main Results:
- Restoring physiological GnRH levels in Ts65Dn mice ameliorated olfactory and cognitive deficits.
- Pulsatile GnRH therapy demonstrated improvements in cognition and brain connectivity in adult DS patients.
- GnRH was identified as a critical factor in olfactory and cognitive function.
Conclusions:
- Gonadotropin-releasing hormone (GnRH) plays a vital role in olfactory and cognitive functions, particularly in the context of Down syndrome (DS).
- Pulsatile GnRH therapy represents a promising therapeutic strategy for addressing cognitive impairments and neurological deficits in individuals with DS.
